Dataset Information


Neurotrophin Genes and Antidepressant-Worsening Suicidal Ideation: A Prospective Case-Control Study.

ABSTRACT: Antidepressant-worsening suicidal ideation is a rare but serious phenomenon. This study aimed to test for association between antidepressant-worsening suicidal ideation and polymorphisms of BDNF/NTRK2 neurotrophin pathway genes, known to be involved in depression and suicide.This was a case-control study comparing patients with antidepressant-worsening suicidal ideation to patients without. Patients were collected from the GENESE cohort (3771 depressed tianeptine-treated outpatients). Antidepressant-worsening suicidal ideation was defined by an increase of at least 2 points on the Montgomery-Åsberg Depression Rating Scale-item10 during treatment. Controls were matched for age, sex, and baseline Montgomery-Åsberg Depression Rating Scale-item10 score. Thirteen single nucleotide polymorphisms covering 5 BDNF/NTRK2 pathway genes were genotyped.A total 78 cases and 312 controls were included. Two NTRK2 single nucleotide polymorphisms were associated to antidepressant-worsening suicidal ideation: rs1439050 (P=.01) and rs1867283 (P=.04). Association with rs1439050 remained significant after adjustment for potentially confounding factors, including previous suicide attempts (P<.01).This naturalistic prospective study is consistent with previous studies on highlighting the potential role of the neurotrophin pathway, and especially of NTRK2, in antidepressant-worsening suicidal ideation.


PROVIDER: S-EPMC5137276 | BioStudies | 2016-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7502493 | BioStudies
2019-01-01 | S-EPMC6385304 | BioStudies
2017-01-01 | S-EPMC5706927 | BioStudies
2009-01-01 | S-EPMC2768737 | BioStudies
2010-01-01 | S-EPMC3012738 | BioStudies
2018-01-01 | S-EPMC5794524 | BioStudies
2019-01-01 | S-EPMC6897901 | BioStudies
2010-01-01 | S-EPMC2921883 | BioStudies
1000-01-01 | S-EPMC6259000 | BioStudies
2012-01-01 | S-EPMC3343177 | BioStudies